Astrocyte Senescence as a Component of Alzheimer's Disease

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Bhat, Rekha ^a   Crowe, Elizabeth P ^a   Bitto, Alessandro ^a   Moh, Michelle ^a   Katsetos, Christos D ^a   Garcia, Fernando U ^a   Johnson, Frederick Bradley ^b   Trojanowski, John Q ^b   Sell, Christian ^a   Torres, Claudio ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL AGING; CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; ENZYME REGULATION; FETUS; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEUROPATHOLOGY; PROTEIN EXPRESSION; SENESCENCE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; CELL AGING; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 1; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS;

EID: 84866316014     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045069     Document Type: Article

References (62)

1. Thies W, Bleiler L, (2011) 2011 Alzheimer's disease facts and figures. Alzheimers Dement 7: 208-244.
2. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM, (2006) Cellular senescence in aging primates. Science 311: 1257.
3. Jeyapalan JC, Sedivy JM, (2008) Cellular senescence and organismal aging. Mech Ageing Dev 129: 467-474.
4. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
5. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U, (2007) Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128: 36-44.
6. Rodier F, Campisi J, (2011) Four faces of cellular senescence. J Cell Biol 192: 547-556.
7. Campisi J, Andersen JK, Kapahi P, Melov S, (2011) Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol 21: 354-359.
8. Coppe JP, Desprez PY, Krtolica A, Campisi J, (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5: 99-118.
9. Baker DJ, Wijshake T, Tchkonia T, Lebrasseur NK, Childs BG, et al. (2011) Clearance of p16(Ink4a)-positive senescent cells delays ageing-associated disorders. Nature.
10. Sofroniew MV, Vinters HV, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35.
11. Halassa MM, Fellin T, Haydon PG, (2009) Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57: 343-346.
12. Pertusa M, Garcia-Matas S, Rodriguez-Farre E, Sanfeliu C, Cristofol R, (2007) Astrocytes aged in vitro show a decreased neuroprotective capacity. J Neurochem 101: 794-805.
13. Bitto A, Sell C, Crowe E, Lorenzini A, Malaguti M, et al. (2010) Stress-induced senescence in human and rodent astrocytes. Exp Cell Res 316: 2961-2968.
14. Salminen A, Ojala J, Kaarniranta K, Haapasalo A, Hiltunen M, et al. (2011) Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur J Neurosci 34: 3-11.
15. Abramov AY, Canevari L, Duchen MR, (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24: 565-575.
16. Rhein V, Baysang G, Rao S, Meier F, Bonert A, et al. (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 29: 1063-1071.
17. Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, et al. (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30: 3326-3338.
18. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH, (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
19. Freir DB, Fedriani R, Scully D, Smith IM, Selkoe DJ, et al. (2011) Abeta oligomers inhibit synapse remodelling necessary for memory consolidation. Neurobiol Aging 32: 2211-2218.
20. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, et al. (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27: 2866-2875.
21. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842.
22. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84.
23. Davalos AR, Coppe JP, Campisi J, Desprez PY, (2010) Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 29: 273-283.
24. Maggio M, Guralnik JM, Longo DL, Ferrucci L, (2006) Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61: 575-584.
25. Freund A, Orjalo AV, Desprez PY, Campisi J, (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16: 238-246.
26. Heneka MT, O'Banion MK, (2007) Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184: 69-91.
27. Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, et al. (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 5: 379-389.
28. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, et al. (2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114: 1299-1307.
29. Association As, (2012) Alzheimer's disease facts and figures. Alzheimer's and Dementia: The Journal of the Alzheimer's Association 8: 131-168.
30. Livney MG, Clark CM, Karlawish JH, Cartmell S, Negron M, et al. (2011) Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center. Am J Geriatr Psychiatry 19: 430-439.
31. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA, (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60: 1119-1122.
32. Chkhotua AB, Gabusi E, Altimari A, D'Errico A, Yakubovich M, et al. (2003) Increased expression of p16(INK4a) and p27(Kip1) cyclin-dependent kinase inhibitor genes in aging human kidney and chronic allograft nephropathy. Am J Kidney Dis 41: 1303-1313.
33. Tsuji T, Aoshiba K, Nagai A, (2006) Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 174: 886-893.
34. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, et al. (2003) Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 93: 604-613.
35. Wang HY, D'Andrea MR, Nagele RG, (2002) Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells. Neurobiol Aging 23: 213-223.
36. Li YT, Woodruff-Pak DS, Trojanowski JQ, (1994) Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites. Neurobiol Aging 15: 1-9.
37. West MD, Pereira-Smith OM, Smith JR, (1989) Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res 184: 138-147.
38. Coppe JP, Rodier F, Patil CK, Freund A, Desprez PY, et al. (2011) Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem 286: 36396-36403.
39. Iwasa H, Han J, Ishikawa F, (2003) Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8: 131-144.
40. Freund A, Patil CK, Campisi J, (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 30: 1536-1548.
41. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, et al. (2011) Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta). J Neuroinflammation 8: 79.
42. Munoz L, Ammit AJ, (2010) Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology 58: 561-568.
43. Myung NH, Zhu X, Kruman, II, Castellani RJ, Petersen RB, et al. (2008) Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr) 30: 209-215.
44. Ahronheim JC, Bernholc AS, Clark WD, (1983) Age trends in autopsy rates. Striking decline in late life. JAMA 250: 1182-1186.
45. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853-2868.
46. Tresini M, Mawal-Dewan M, Cristofalo VJ, Sell C, (1998) A phosphatidylinositol 3-kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts. Cancer Res 58: 1-4.
47. Zeng G, Millis AJ, (1996) Differential regulation of collagenase and stromelysin mRNA in late passage cultures of human fibroblasts. Exp Cell Res 222: 150-156.
48. Golde TE, Miller VM, (2009) Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res Ther 1: 5.
49. Donnini S, Solito R, Cetti E, Corti F, Giachetti A, et al. (2010) Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. FASEB J 24: 2385-2395.
50. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866.
51. Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ, (1998) Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res 785: 195-206.
52. Hou L, Liu Y, Wang X, Ma H, He J, et al. (2011) The effects of amyloid-beta42 oligomer on the proliferation and activation of astrocytes in vitro. In Vitro Cell Dev Biol Anim 47: 573-580.
53. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
54. Verkhratsky A, Sofroniew MV, Messing A, Delanerolle NC, Rempe D, et al. (2012) Neurological diseases as primary gliopathies: A reassessment of neurocentrism. ASN Neuro.
55. Hamby ME, Sofroniew MV, (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7: 494-506.
56. Fa M, Orozco IJ, Francis YI, Saeed F, Gong Y, et al. (2010) Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. J Vis Exp.
57. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ, (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278: 11612-11622.
58. Koo EH, Squazzo SL, (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269: 17386-17389.
59. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ, (2000) The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39: 10831-10839.
60. Poling A, Morgan-Paisley K, Panos JJ, Kim EM, O'Hare E, et al. (2008) Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures. Behav Brain Res 193: 230-234.
61. Puck TT, Cieciura SJ, Robinson A, (1958) Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects. J Exp Med 108: 945-956.
62. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.